Rechercher des projets européens

moting Cross-Border Partnership Between Estonia and Latvia for Development of Antiviral Drugs (EstLat Pharma)
Date du début: 31 juil. 2011, Date de fin: 30 juil. 2012 PROJET  TERMINÉ 

Active community cooperation will start between the activists in Tartu and Riga, interested in participation in the planning of the urban living environment. There will be number of people to people cooperation activities and active networking among several non-profit organisations, including the main implementers - Estonian Urban Lab and Society Technologies Foundation in Latvia. Achievements: This was a cooperation between two private companies: an Estonian contract research company TBD-Biodiscovery experienced in synthesis of chemicals for pharmaceutical markets, and a Latvian pharma company Grindex with extensive experience in pharmaceutical market and big scale production. This cross-border partnership allowed to combine the complementary competences promoting the development of innovative product - new generic antiviral drug, that is now available. The project contributed to the increased export sales of the region, originated from the economic activities with higher value added. Also the competitiveness and experience of the regional companies allowing to start projects for production of other niche pharmaceuticals for EU and other international markets increased. Success and remarkable results made it possible to create knowledge based and highly paid jobs in the region (e.g. 15 positions by 2015 for TBD-Biodiscovery). More information please find at:



  • 50%   139 900,00
  • 2007 - 2013 Estonia - Latvia (EE-LV)
  • Projet sur KEEP platform
Projet Website

1 Participants partenaires